Form 4: Dexcom Executive Michael Brown Sells Shares Under 10b5-1 Plan
SEC Form 4
Michael Brown, EVP and Chief Legal Officer of Dexcom Inc., sold 686 shares of common stock at $70 per share on August 30, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On August 30, 2024, Michael Brown, the EVP and Chief Legal Officer of Dexcom Inc., sold 686 shares of Dexcom's common stock.
- The sale was executed at a price of $70 per share.
- This transaction was conducted under a 10b5-1 trading plan adopted on December 15, 2022, and amended on August 29, 2023, which allows for the orderly disposition of shares.
- Following the transaction, Brown directly owns 65,636 shares of Dexcom, which includes 60,303 unvested restricted stock units and 73 shares acquired under the employee stock purchase plan.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence and are often planned in advance to avoid any appearance of insider trading. The use of a 10b5-1 plan allows executives to sell shares at predetermined times and prices.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 2022-12-15 | Mr. Brown adopted a 10b5-1 Plan. |
| 2023-08-29 | Mr. Brown's 10b5-1 Plan was amended. |
| 2024-03-08 | Grant date for 21,711 unvested restricted stock units that shall vest through March 8, 2027. |
| 2024-03-08 | Grant date for 14,512 unvested restricted stock units that shall vest through March 8, 2026. |
| 2024-03-08 | Grant date for 24,080 unvested restricted stock units that shall vest through March 8, 2026. |
| 2024-08-30 | Date of the stock sale transaction and acquisition of 73 shares under the issuers 2015 Employee Stock Purchase Plan. |
| 2024-09-03 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.